South Korea vs Moldova: New cases tested for RR-/MDR-TB
South Korea
100.0%
in 2024
Moldova
100.0%
in 2024
South Korea rank
1st
Moldova rank
1st
New cases tested for RR-/MDR-TB over time
- South Korea
- Moldova
How they compare
South Korea currently reports 100.0% against 100.0% in Moldova, a difference of 0.0%.
The two have swapped places 4 times across 13 shared years of data; in 2011 it was Moldova ahead.
South Korea ranks 1st and Moldova ranks 1st of 192 countries.
Moldova has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.6% | 93.9% | 15.2% | Moldova |
| 2020s | 94.2% | 98.0% | 3.8% | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, South Korea or Moldova?
- South Korea, at 100.0% against 100.0% in Moldova as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between South Korea and Moldova?
- 0.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Moldova?
- 13 years are reported by both, from 2011 to 2024.
- How do South Korea and Moldova rank globally for new cases tested for rr-/mdr-tb?
- South Korea ranks 1st and Moldova ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.